Drug intelligence / Profile preview

clonidine + ketamine + magnesium sulfate

Development stage
Preclinical
Lead developer
Boehringer Ingelheim
Modality
Small Molecules
Administration
Intravenous
01

Overview

A combination therapy consisting of clonidine, ketamine, and magnesium sulfate used primarily for pain management, particularly for neuropathic pain. This combination leverages synergistic effects between the three medications to enhance analgesic efficacy while potentially reducing side effects. ## Mechanism of Action - **Ketamine** acts as an NMDA receptor antagonist, blocking pain transmission pathways - **Magnesium sulfate** functions as the body's natural NMDA receptor antagonist, binding to the receptor channel at rest and increasing ketamine's binding affinity for NMDA receptors - **Clonidine** works primarily as an alpha-2 adrenoceptor agonist, causing central hypotensive effects and decreasing transmission of pain signals at the spine The combination appears particularly effective because magnesium enhances ketamine's analgesic properties, while clonidine provides additional pain relief through a different mechanism.

02

Targets

ADRA2C (α2C)NMDAR (Glutamate receptor ionotropic, NMDA)ADRA2A (α2A)ADRA2B (α2B)

Beyond the preview

Go deeper on clonidine + ketamine + magnesium sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clonidine + ketamine + magnesium sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call